Related Experiment Video
Updated: Sep 22, 2025

07:16
Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
13.7K
Retraction Note: γ-Aminobutyric acid (GABA) administration improves action selection processes: a randomised
Laura Steenbergen1, Roberta Sellaro2, Ann-Kathrin Stock3
1Institute for Psychological Research, Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands. l.steenbergen@fsw.leidenuniv.nl.
Scientific Reports
|May 25, 2022
Summary
No abstract available in PubMed .
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
695
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
695
Antiepileptic Drugs: Potassium Channel Activators
294
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
294

